# A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode

> **NCT01417078** · PHASE2 · COMPLETED · sponsor: **Acorda Therapeutics** · enrollment: 31 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Diazepam

## Key facts

- **NCT ID:** NCT01417078
- **Lead sponsor:** Acorda Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417078, "A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01417078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*